March Biosciences, Inc.
🇺🇸United States
MB-105 in Patients With CD5 Positive T-cell Lymphoma
Phase 2
Recruiting
- Conditions
- Lymphoma, T-Cell
- First Posted Date
- 2024-08-02
- Last Posted Date
- 2025-05-08
- Lead Sponsor
- March Biosciences Inc
- Target Recruit Count
- 46
- Registration Number
- NCT06534060
- Locations
- 🇺🇸
University of San Diego (UCSD)-Moores Cancer Center, San Diego, California, United States
🇺🇸SCRI - Colorado Blood Cancer Institute (CBCI), Denver, Colorado, United States
🇺🇸Moffitt Cancer Center Magnolia Campus, Tampa, Florida, United States
© Copyright 2025. All Rights Reserved by MedPath